SCHEMBL343948

SCHEMBL343948

CC(C)(C)Cc1cccc(C(=O)O)c1C(=O)O.[KH]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 3/20 0.43
ALOX15 P16050 2/20 0.42
CLCN2 P51788 1/20 0.41
HMGB1 P09429 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RIPK1 Q13546 1/20 0.38
TSHR P16473 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
KMT2A Q03164 1/20 0.37
BID P55957 3/20 0.36
MCL1 Q07820 3/20 0.36
BCL2L1 Q07817 2/20 0.36
BAK1 Q16611 2/20 0.36
KAT8 Q9H7Z6 2/20 0.36
HTT P42858 1/20 0.36
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6906894 0.98 FOLH1 (0.44) FOLH1ALOX15CLCN2HMGB1ALDH1A1
SCHEMBL28863329 0.87 HMGB1 (0.38) FOLH1ALOX15CLCN2HMGB1ALDH1A1
SCHEMBL9724027 0.85 AKR1C3 (0.49) FOLH1ALOX15CLCN2ALDH1A1TSHR
SCHEMBL5048768 0.82 FOLH1 (0.53) FOLH1ALOX15CLCN2HMGB1ALDH1A1
SCHEMBL21651081 0.81 BID (0.55) ALOX15KDM4EHSD17B10BIDMCL1
SCHEMBL21771814 0.80 BID (0.44) ALOX15CLCN2KDM4EHSD17B10TSHR
SCHEMBL123735 0.80 CLCN2 (0.54) FOLH1ALOX15CLCN2HMGB1ALDH1A1
SCHEMBL9498502 0.79 AKR1C3 (0.48) FOLH1ALOX15ALDH1A1HSD17B10CYP3A4
SCHEMBL21651053 0.79 RIPK1 (0.38) FOLH1KDM4ERIPK1BIDMCL1
SCHEMBL10646485 0.79 FOLH1 (0.43) FOLH1ALOX15CLCN2HMGB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120016152-A1 Process for the preparation of 4`-haloalkylbiphenyl-2-carboxylic acids SALTIGO GMBH (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016152-A1 Process for the preparation of 4`-haloalkylbiphenyl-2-carboxylic acids CYP4B1, HACL2, UGT1A4 FOLH1 1070/4885ALOX15 1457/4885CLCN2 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.